Detalhe da pesquisa
1.
Development and Update of Guideline-based Quality Indicators in Lung Cancer.
Pneumologie
; 78(4): 250-261, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38081218
2.
RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape.
Oncologist
; 28(5): 402-413, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36821595
3.
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC.
N Engl J Med
; 383(14): 1328-1339, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32997907
4.
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
N Engl J Med
; 383(10): 931-943, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469185
5.
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis.
Strahlenther Onkol
; 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37975883
6.
Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment.
Eur J Nucl Med Mol Imaging
; 50(8): 2466-2476, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951991
7.
Plain language summary of the development of tepotinib: a treatment for a subtype of non-small cell lung cancer called MET exon 14 skipping.
Future Oncol
; 19(10): 683-696, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999526
8.
[Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer - Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version]. / Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms.
Pneumologie
; 77(10): 671-813, 2023 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-37884003
9.
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition.
Invest New Drugs
; 40(1): 163-171, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351518
10.
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition.
Eur J Nucl Med Mol Imaging
; 49(4): 1407-1416, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664091
11.
Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians.
Respiration
; 101(3): 307-320, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35231915
12.
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Lancet Oncol
; 22(1): 51-65, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33285097
13.
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients.
Invest New Drugs
; 39(4): 1189-1196, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704621
14.
Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave.
Pneumologie
; 75(12): 960-970, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261146
15.
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Lancet
; 394(10212): 1929-1939, 2019 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31590988
16.
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 20(7): 924-937, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31122901
17.
[Small Cell Lung Cancer]. / Kleinzelliges Lungenkarzinom.
Zentralbl Chir
; 143(1): 103-116, 2018 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-29486510
18.
Immunotherapy for small-cell lung cancer: emerging evidence.
Future Oncol
; 12(7): 931-43, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26882955
19.
Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer.
Eur Respir J
; 46(1): 219-29, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25792638
20.
Novel angiogenesis inhibitors in nonsmall cell lung cancer.
Curr Opin Oncol
; 27(2): 79-86, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25602682